CG-416

N/A

Report date: 2023/03/02 16:29:24
NME

Base Information

Drug NameCG-416
Drug Alias NameCG-416
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionNerve growth factor receptor Trk-A degraders
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCullgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesCullgen Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A